Iranian Red Crescent Medical Journal

Published by: Kowsar

Factors Associated With Serum Albumin in Diabetes Mellitus Type 2 With Microalbuminuria Using Non-Normal Mixed Models: A Prospective Cohort Study

Batoul Khoundabi 1 , Anoshirvan Kazemnejad 1 , * , Marjan Mansourian 2 and Elham Faghihimani 3
Authors Information
1 Department of Biostatistics, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, IR Iran
2 Department of Epidemiology and Biostatistics, School of Public Health, Isfahan University of Medical Sciences, Isfahan, IR Iran
3 Department of Internal Medicine, Isfahan Endocrine and Metabolism Research Center, Isfahan University of Medical Sciences, Isfahan, IR Iran
Article information
  • Iranian Red Crescent Medical Journal: January 01, 2016, 18 (1); e20671
  • Published Online: January 2, 2016
  • Article Type: Research Article
  • Received: May 26, 2014
  • Revised: July 6, 2014
  • Accepted: August 5, 2014
  • DOI: 10.5812/ircmj.20671

To Cite: Khoundabi B, Kazemnejad A, Mansourian M, Faghihimani E. Factors Associated With Serum Albumin in Diabetes Mellitus Type 2 With Microalbuminuria Using Non-Normal Mixed Models: A Prospective Cohort Study, Iran Red Crescent Med J. 2016 ; 18(1):e20671. doi: 10.5812/ircmj.20671.

Abstract
Copyright © 2016, Iranian Red Crescent Medical Journal. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
Acknowledgements
Footnote
References
  • 1. Kundu D, Roy A, Mandal T, Bandyopadhyay U, Ghosh E, Ray D. Relation of microalbuminuria to glycosylated hemoglobin and duration of type 2 diabetes. Niger J Clin Pract. 2013; 16(2): 216-20[DOI][PubMed]
  • 2. Rani PK, Raman R, Gupta A, Pal SS, Kulothungan V, Sharma T. Albuminuria and Diabetic Retinopathy in Type 2 Diabetes Mellitus Sankara Nethralaya Diabetic Retinopathy Epidemiology And Molecular Genetic Study (SN-DREAMS, report 12). Diabetol Metab Syndr. 2011; 3(1): 9[DOI][PubMed]
  • 3. García-Donaire JA, Ruilope LM. Reducing both microalbuminuria and cardiovascular events: how easy is it to reach this target? Medicographia. 2012; 34: 48-56
  • 4. Cerasola G, Cottone S, Mulè G. The progressive pathway of microalbuminuria: from early marker of renal damage to strong cardiovascular risk predictor. J Hypertension. 2010; : 1[DOI]
  • 5. Agaba EI, Agaba PA, Puepet FH. Prevalence of microalbuminuria in newly diagnosed type 2 diabetic patients in Jos Nigeria. Afr J Med Med Sci. 2004; 33(1): 19-22[PubMed]
  • 6. Cederholm J, Eliasson B, Nilsson PM, Weiss L, Gudbjornsdottir S, Steering Committee of the Swedish National Diabetes R. Microalbuminuria and risk factors in type 1 and type 2 diabetic patients. Diabetes Res Clin Pract. 2005; 67(3): 258-66[DOI][PubMed]
  • 7. Thomas RL, Dunstan F, Luzio SD, Roy Chowdury S, Hale SL, North RV, et al. Incidence of diabetic retinopathy in people with type 2 diabetes mellitus attending the Diabetic Retinopathy Screening Service for Wales: retrospective analysis. BMJ. 2012; 344[DOI]
  • 8. Aekplakorn W, Srivanichakorn S, Sangwatanaroj S. Microalbuminuria and metabolic risk factors in patients with type 2 diabetes in primary care setting in Thailand. Diabetes Res Clin Pract. 2009; 84(1): 92-8[DOI][PubMed]
  • 9. Sarnak MJ, Katz R, Newman A, Harris T, Peralta CA, Devarajan P, et al. Association of urinary injury biomarkers with mortality and cardiovascular events. J Am Soc Nephrol. 2014; 25(7): 1545-53[DOI][PubMed]
  • 10. Mongkolsomlit S, Patumanond J, Tawichasril C, Komoltri C, Rawdaree P. Meta-regression of risk factors for microalbuminuria in type 2 diabetes. Southeast Asian J Trop Med Public Health. 2012; 43(2): 455-66[PubMed]
  • 11. Ritz E, Menne J, Haller H. Prevalence of microalbuminuria in type 2 diabetes: lessons learned from the ROADMAP study. Nephrol Dialysis Transplant. 2012; 27-30[DOI]
  • 12. Lin TI, Wang WL. Multivariate skew-normal at linear mixed models for multi-outcome longitudinal data. Statistic Model. 2013; 13(3): 199-221[DOI]
  • 13. Mansourian M, Kazemnejad A, Kazemi I, Zayeri F, Soheilian M. Bayesian analysis of longitudinal ordered data with flexible random effects using McMC: application to diabetic macular Edema data. J Appl Statistic. 2012; 39(5): 1087-100[DOI]
  • 14. Arnau J, Bono R, Blanca MJ, Bendayan R. Using the linear mixed model to analyze nonnormal data distributions in longitudinal designs. Behav Res Methods. 2012; 44(4): 1224-38[DOI][PubMed]
  • 15. Genton M. Skew-elliptical distributions and their applications: a journey beyond normality. 2004; : 116-30[DOI]
  • 16. Jara A, Quintana F, San Martín E. Linear mixed models with skew-elliptical distributions: A Bayesian approach. Computat Statistics Data Analysis. 2008; 52(11): 5033-45[DOI]
  • 17. Bandyopadhyay D, Lachos VH, Castro LM, Dey DK. Skew-normal/independent linear mixed models for censored responses with applications to HIV viral loads. Biom J. 2012; 54(3): 405-25[DOI][PubMed]
  • 18. Kazemi I, Mahdiyeh Z, Mansourian M, Park JJ. Bayesian analysis of multivariate mixed models for a prospective cohort study using skew-elliptical distributions. Biom J. 2013; 55(4): 495-508[DOI][PubMed]
  • 19. Azzalini A, Capitanio A. Statistical applications of the multivariate skew normal distribution. J Royal Statistic Soc. 1999; 61(3): 579-602[DOI]
  • 20. Rohani F, Hooman N, Moradi S, Mobarra M, Najafizadeh M, Tatarpoor P. The Prevalence of Pre-hypertension in Children with Type 1 Diabetes Mellitus. Int J Prev Med. 2014; 5-9[PubMed]
  • 21. Hsu CC, Chang HY, Huang MC, Hwang SJ, Yang YC, Lee YS, et al. HbA1c variability is associated with microalbuminuria development in type 2 diabetes: a 7-year prospective cohort study. Diabetologia. 2012; 55(12): 3163-72[DOI][PubMed]
  • 22. Atta MG, Baptiste-Roberts K, Brancati FL, Gary TL. The natural course of microalbuminuria among African Americans with type 2 diabetes: a 3-year study. Am J Med. 2009; 122(1): 62-72[DOI][PubMed]
  • 23. Tuomilehto J, Lindstrom J, Eriksson JG, Valle TT, Hamalainen H, Ilanne-Parikka P, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med. 2001; 344(18): 1343-50[DOI][PubMed]
  • 24. Konta T, Hao Z, Abiko H, Ishikawa M, Takahashi T, Ikeda A, et al. Prevalence and risk factor analysis of microalbuminuria in Japanese general population: the Takahata study. Kidney Int. 2006; 70(4): 751-6[DOI][PubMed]
  • 25. Enhesari A, Yoosefzadeh G, Hashemi SMJ. Comparison of Diagnostic Value of Intrarenal Doppler Indices and Microalbuminuria for Detection of Diabetic Nephropathy in Type II Diabetic Patients. J Kerman Univ Med Sci. 2011; 18(1): 10-5
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments